Quality specifications for cardiac troponin assays

被引:162
作者
Panteghini, M [1 ]
Gerhardt, W
Apple, FS
Dati, F
Ravkilde, J
Wu, AH
机构
[1] Azienda Osped Spedali Civili, Lab Anal Chim Clin 1, I-25125 Brescia, Italy
[2] Lasarettet, Dept Clin Chem, Helsingborg, Sweden
[3] Hennepin Cty Med Ctr, Clin Labs, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA
[4] TUV Rheinland Prod Safety GmbH, Cologne, Germany
[5] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[6] Hartford Hosp, Clin Chem Lab, Hartford, CT 06115 USA
关键词
recommendations; IFCC; quality specifications; immunoassay; myocardial infarction; troponin I; troponin T;
D O I
10.1515/cclm.2001.39.2.175
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The objective of this report is to help to improve the quality of immunochemical determinations of cardiac troponins. The guidelines are intended for use by the manufacturers of commercial assays and by clinical laboratories performing troponin analyses. The main goals of the document are that: 1. Manufacturers endorse, or at the minimum, address the enclosed recommendations. 2. All package inserts for troponin immunoassay procedures include information on method design, and on pre-analytical and analytical performance characteristics as outlined in this document. 3. Manufacturers and the scientific community select and design research projects that further the knowledge and the definition of the issues addressed in this document.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 27 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]  
[Anonymous], EV PREC PERF CLIN CH
[3]  
Apple F, 2000, CLIN CHEM, V46, pA76
[4]  
Apple FS, 1999, CLIN CHEM, V45, P18
[5]  
BURNETT RW, 1980, CLIN CHEM, V26, P644
[6]  
Dati F, 1999, SCAND J CLIN LAB INV, V59, P113
[7]  
Fitzmaurice TF, 1998, CLIN CHEM, V44, P2212
[8]  
Gerhardt W, 2000, CLIN CHEM, V46, P817
[9]   Biochemical factors influencing measurement of cardiac troponin I in serum [J].
Katrukha, A ;
Bereznikova, A ;
Filatov, V ;
Esakova, T .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (11-12) :1091-1095
[10]  
Katrukha A, 1999, SCAND J CLIN LAB INV, V59, P124